JP2006506948A5 - - Google Patents

Download PDF

Info

Publication number
JP2006506948A5
JP2006506948A5 JP2003584268A JP2003584268A JP2006506948A5 JP 2006506948 A5 JP2006506948 A5 JP 2006506948A5 JP 2003584268 A JP2003584268 A JP 2003584268A JP 2003584268 A JP2003584268 A JP 2003584268A JP 2006506948 A5 JP2006506948 A5 JP 2006506948A5
Authority
JP
Japan
Prior art keywords
raav
composition
scfvx5
igg1b12
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003584268A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006506948A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/010865 external-priority patent/WO2003087324A2/en
Publication of JP2006506948A publication Critical patent/JP2006506948A/ja
Publication of JP2006506948A5 publication Critical patent/JP2006506948A5/ja
Withdrawn legal-status Critical Current

Links

JP2003584268A 2002-04-09 2003-04-09 抗体遺伝子送達およびそのための組換えａａｖ Withdrawn JP2006506948A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37150102P 2002-04-09 2002-04-09
PCT/US2003/010865 WO2003087324A2 (en) 2002-04-09 2003-04-09 Antibody gene transfer and recombinant aav

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009238783A Division JP2010006846A (ja) 2002-04-09 2009-10-15 抗体遺伝子送達およびそのための組換えａａｖ

Publications (2)

Publication Number Publication Date
JP2006506948A JP2006506948A (ja) 2006-03-02
JP2006506948A5 true JP2006506948A5 (enExample) 2006-07-06

Family

ID=29250690

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003584268A Withdrawn JP2006506948A (ja) 2002-04-09 2003-04-09 抗体遺伝子送達およびそのための組換えａａｖ
JP2009238783A Pending JP2010006846A (ja) 2002-04-09 2009-10-15 抗体遺伝子送達およびそのための組換えａａｖ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009238783A Pending JP2010006846A (ja) 2002-04-09 2009-10-15 抗体遺伝子送達およびそのための組換えａａｖ

Country Status (6)

Country Link
US (3) US20030219733A1 (enExample)
EP (3) EP2036985A1 (enExample)
JP (2) JP2006506948A (enExample)
AU (1) AU2003223517A1 (enExample)
CA (1) CA2481813A1 (enExample)
WO (1) WO2003087324A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070041943A1 (en) * 2004-12-29 2007-02-22 Children's Hospital Research Expression of virus entry inhibitors and recombinant AAV thereof
US9725485B2 (en) 2012-05-15 2017-08-08 University Of Florida Research Foundation, Inc. AAV vectors with high transduction efficiency and uses thereof for gene therapy
US9611302B2 (en) 2007-04-09 2017-04-04 University Of Florida Research Foundation, Inc. High-transduction-efficiency RAAV vectors, compositions, and methods of use
DK2623605T3 (en) 2007-04-09 2019-03-25 Univ Florida RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
EP2910637A1 (en) 2008-05-20 2015-08-26 University of Florida Research Foundation, Inc. Vectors for delivery of light-sensitive proteins and methods of use
EP2172481B1 (en) * 2008-10-06 2014-10-29 Novoplant GmbH Proteolytically stable antibody formats
WO2010040545A1 (en) * 2008-10-06 2010-04-15 Novoplant Gmbh Proteolytically stable antibody formats
JP6091435B2 (ja) * 2011-02-22 2017-03-08 カリフォルニア インスティチュート オブ テクノロジー アデノ随伴ウイルス（ａａｖ）ベクターを用いたタンパク質の送達
CN102634542B (zh) * 2012-04-12 2014-03-26 北京工业大学 一种表达人抗体全基因的重组腺相关病毒(rAAV)载体及其方法
US10294281B2 (en) 2012-05-15 2019-05-21 University Of Florida Research Foundation, Incorporated High-transduction-efficiency rAAV vectors, compositions, and methods of use
US12358954B2 (en) 2012-05-15 2025-07-15 University Of Florida Research Foundation, Incorporated Capsid-modified rAAV vector compositions and methods therefor
CN102690842B (zh) * 2012-06-12 2014-04-23 北京工业大学 一种表达人抗体全基因的重组腺病毒(rAdv)载体及其方法
WO2014052693A2 (en) 2012-09-29 2014-04-03 The Trustees Of The University Of Pennsylvania Veterinary composition and methods for non-surgical neutering and castration
GB201308658D0 (en) * 2013-05-14 2013-06-26 Isis Innovation Antibodies
WO2016126857A1 (en) 2015-02-03 2016-08-11 University Of Florida Research Foundation, Inc. Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
EP3448987A4 (en) * 2016-04-29 2020-05-27 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
FR3080621B1 (fr) * 2018-04-26 2022-12-09 Univ Limoges Nouvelle classe d'immunoglobuline recombinante de type g : igg5, codee par le pseudo-gene gamma humain de chaine lourde
US20220195462A1 (en) * 2019-04-24 2022-06-23 Regenxbio Inc. Fully-human post-translationally modified antibody therapeutics
EP3966227A1 (en) 2019-05-07 2022-03-16 Voyager Therapeutics, Inc. Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation
EP4211252A1 (en) * 2020-09-09 2023-07-19 Homology Medicines, Inc. Vectorized antibodies and uses thereof
WO2026102093A1 (en) 2024-11-07 2026-05-15 Voyager Therapeutics, Inc. Compositions and methods for the treatment of tau-related disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US371501A (en) 1887-10-11 Disteict
US5658785A (en) * 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
US20020159979A1 (en) * 1994-06-06 2002-10-31 Children's Hospital, Inc. Adeno-associated virus materials and methods
WO1999014354A1 (en) * 1997-09-19 1999-03-25 The Trustees Of The University Of The Pennsylvania Methods and vector constructs useful for production of recombinant aav
US6953690B1 (en) * 1998-03-20 2005-10-11 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
WO1999057272A1 (en) * 1998-05-04 1999-11-11 The Mount Sinai School Of Medicine Of New York University Peptide inhibitors of hiv replication
US20010034062A1 (en) * 2000-02-09 2001-10-25 Scott Koenig Antibody gene therapy with adeno-associated viral vectors
AU2002337885B1 (en) * 2001-10-16 2003-04-28 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Broadly cross-reactive neutralizing antibodies against human ummunodeficiency virus selected by Env-CD4-co-receptor complexes
US20070041943A1 (en) * 2004-12-29 2007-02-22 Children's Hospital Research Expression of virus entry inhibitors and recombinant AAV thereof

Similar Documents

Publication Publication Date Title
JP2009268467A5 (enExample)
JP2005537211A5 (enExample)
ATE500267T1 (de) Multifunktionelle cytokine
JP2005120106A5 (enExample)
WO2002078524A3 (en) Translational profiling
ATE348883T1 (de) Zusammensetzungen und verfahren mit analogen von g-csf
ATE471340T1 (de) Peptide der amylin familie, verfahren zu deren herstellung und verwendung
DE60142922D1 (de) Für antigene polypeptide des hiv type c kodierende nukleinsäuren, entsprechende polypeptide und verwendungen davon
WO2007143490A3 (en) Composition containing aziridino groups, method of production and use thereof
PL1675956T3 (pl) Minimalna sekwencja DNA działająca jako insulator chromatyny i jej zastosowanie do wyrażania białek
HRP20140888T1 (hr) Humana monoklonalna protutijela za humani il-4
NO20063374L (no) Fremgangsmate for fremstilling av tumornekrosefaktor-proteinbindinger
WO2003008449A8 (en) Ntb-a, a surface molecule involved in natural killer cells activity
JP2004500380A5 (enExample)
WO2008133141A1 (ja) オスモチン組換えタンパク質およびその製造方法、並びにその利用
WO2008041863A8 (en) Novel genes and polypeptides associated with insecticidal activity
JP2006506332A5 (enExample)
DK1773994T3 (da) Polypeptid
DK1423525T3 (da) Rekombinant MVA, der kan eksprimere HCV-strukturantigener
GB9916703D0 (en) Viral protein binding compositions and methods
NO20075070L (no) rekombinant E-selektin fremstilt i insektceller
JP2005535281A5 (enExample)
IL180531A0 (en) Novel sequence for improving expression of nucleic acid
JP2010501580A5 (enExample)
RU2004139054A (ru) Модифицированные фитазы